Arcellx
ACLX
ACLX
117 hedge funds and large institutions have $1.4B invested in Arcellx in 2023 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 46 increasing their positions, 43 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
6% less funds holding
Funds holding: 125 → 117 (-8)
10% less funds holding in top 10
Funds holding in top 10: 10 → 9 (-1)
32% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 22
Holders
117
Holding in Top 10
9
Calls
$1.12M
Puts
$1.19M
Top Buyers
| 1 | +$42.8M | |
| 2 | +$38.3M | |
| 3 | +$35.4M | |
| 4 |
PBA
Paradigm Biocapital Advisors
New York
|
+$27M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$16.1M |
Top Sellers
| 1 | -$18.3M | |
| 2 | -$14.6M | |
| 3 | -$7.98M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$7.76M |
| 5 |
TCM
TimesSquare Capital Management
New York
|
-$6.78M |